Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
How AI Will Continue to Advance Biometric Tech
At Identity Week, Arun Vemury discussed how error rates in facial recognition have dropped over the past decade thanks to machine learning.
12m listen -
TSA is Innovating Digital Identity Solutions with AI
At Identity Week, Jason Lim talked about the ways that digital identity is changing the way people travel securely.
10m listen -
The Security and UX Standards That Power Digital Identity Programs
Live from Identity Week, Ryan Galluzzo discusses the latest draft of NIST's Digital Identity Guidelines for the identity-proofing process.
18m listen -
GSA Cloud Chief Talks FedRAMP 2.0, Automation Hub
Eric Mill shares how a new pilot will inform continuous assessments plus more on software development resources and generative AI.
24m listen